November 19, 2026
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

WHO Condemns US-Funded Hepatitis B Vaccine Trial in Guinea-Bissau as “Unethical”

February 16, 2026

The World Health Organization (WHO) has criticized a US-funded hepatitis B vaccine trial in Guinea-Bissau, calling it "unethical" for proposing to delay life-saving vaccination for thousands of newborns.

The study, led by Danish researchers and funded by the US Health Department, aimed to give one group of babies the hepatitis B vaccine at birth while postponing vaccination for another group until six weeks old. The WHO said this approach exposed infants to “potentially irreversible harm,” given that the birth-dose vaccine is a proven public health intervention with decades of safe use in more than 115 countries.

“Hepatitis B vaccination at birth prevents mother-to-child transmission in 70–95% of cases,” the WHO said. Infection at birth is the most common route to lifelong infection, with 90% of infected newborns becoming chronic carriers.

Guinea-Bissau currently administers the vaccine at six weeks, but authorities plan to roll out the birth-dose nationwide by 2028, in line with global standards. The WHO stressed that the trial could have accelerated this rollout but criticized the study’s scientific justification, ethical safeguards, and alignment with established research standards.

The trial, which was set to involve 14,000 newborns, was suspended last month after public outrage. Critics questioned why babies in Africa were being used for a study that would withhold a proven life-saving intervention.

The US health department overseeing the study is headed by Robert F. Kennedy Jr., who has previously raised doubts about vaccines despite publicly stating that he and his children have been vaccinated. Two months ago, a panel appointed by Kennedy voted to stop recommending hepatitis B vaccination for all US newborns, raising further ethical concerns.

The WHO reiterated that withholding a proven vaccine in a clinical trial is only acceptable when no effective treatment exists. For hepatitis B, the birth-dose vaccine is a critical, life-saving measure.

FBI Warns Businesses Worldwide of AI Tool Enabling Cyberattacks in Under Three Hours

2 days ago

Mike Todd Declared Apostle After Four-Hour Ceremony, Reigniting Debate Over Modern-Day Apostles

2 days ago

Somalia President Accuses UAE of Interference, Calls for National Dialogue

2 days ago

NVIDIA Founder Jensen Huang Apologises, Says He Would Be Honoured to Return as CEO

2 days ago

Uganda’s NRM, China’s CPC Deepen Party-to-Party Cooperation in Institutional Development

2 days ago

Pope Leo XIV Hit in Face by Rosary Thrown From Crowd During Peru Visit

IOM Sets Conditions for Support to EU-Rwanda Migrant Return Hub

“Wealth Declaration Is Not an Option”: IG Warns Leaders Ahead of March 2027 Exercise

UEFA Leaders Endorse French FA Chief Diallo for FIFA Presidency

US Embassies Issue Europe-Wide Security Alert Ahead of Christmas Season

Putin-Xi-Trump Meeting Agenda Revealed Ahead of Shenzhen Summit

FULL LIST: Tems, Asake, Davido, Wizkid and Ayra Starr Lead African Nominations in 2027 Grammy Nominations

3 days ago
South Africa Investigates 17 Deaths in Two Separate Mass Shootings

3 days ago
Romelu Lukaku Retires from International Football After 94 Goals for Belgium

3 days ago
King Oyo Foundation Outlines Plans to Preserve Late Monarch’s Legacy

3 days ago
AU Chief Urges African Leaders to Turn Youth Charter Promises into Jobs

3 days ago
AU, UN, EU and Arab League Condemn Escalating Drone Attacks in Sudan

3 days ago
Uganda Supreme Court Opens Criminal Appeals Session, Targets Cases Dating Back to 2016

3 days ago
Ramaphosa Takes South Africa’s AI Ambitions to Silicon Valley

3 days ago
US Makes U-Turn on Somalia Military Funding as Uganda Plans Troop Exit

3 days ago
Francophonie Leadership Deadlock: Mushikiwabo Gets Another Year as Election Is Postponed

3 days ago
China Confirms Xi Jinping to Host Historic Putin-Trump Trilateral Summit in Shenzhen

3 days ago
PHOTOS: How Comic Relief and Malaria Consortium Transformed Iyolwa Health Centre III

3 days ago

Netanyahu Loses Majority as Israel Certifies Election Results

2 weeks ago

Who Is Melat Kiros? Ethiopian-Born Socialist Wins Colorado Congressional Seat

2 weeks ago

Trump Eyes Third Term Despite Constitutional Two-Term Limit

3 weeks ago

PLU Stops Issuing Muhoozi Endorsement Books

3 weeks ago

UG Diplomat is an independent digital news and media platform dedicated to comprehensive coverage of national politics, regional diplomacy, international relations, geopolitics, defense, and business. Published under Currentarc Media Ltd, we provide authoritative analysis, breaking news, and in-depth reporting on the diplomatic and economic developments shaping East Africa and the global arena.

COMPANY

Contact Us

Privacy Policy

Terms and Conditions

CONTACT INFORMATION

info@ugdiplomat.com

+256774552385

Copyright © 2026 UG Diplomat -Product of CURRENTARC MEDIA